Rocket Pharmaceuticals (RCKT) Depreciation and Depletion (2021 - 2023)

Rocket Pharmaceuticals has reported Depreciation and Depletion for 6 years, with the latest figure at $100000.0 in Q2 2020.

• Quarterly Depreciation and Depletion changed 0.0% year-over-year to $100000.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $419000.0 (up 5.01% YoY) and the FY2019 annual result came in at $426000.0, up 29.09% from the prior year.
• Depreciation and Depletion slipped to $100000.0 in Q2 2020 per RCKT's latest filing, from $118000.0 in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $118000.0 in Q1 2020 and troughed at -$44000.0 in Q4 2016.
• A 5-year average of $69277.8 and a median of $78500.0 in 2018 frame the typical range for Depreciation and Depletion.
• The widest YoY moves for Depreciation and Depletion: up 3500.0% in 2016, down 215.79% in 2016.
• Over 5 years, Depreciation and Depletion stood at -$44000.0 in 2016, then soared by 240.91% to $62000.0 in 2017, then soared by 56.45% to $97000.0 in 2018, then rose by 4.12% to $101000.0 in 2019, then fell by 0.99% to $100000.0 in 2020.
• According to Business Quant data, Depreciation and Depletion over the past three periods registered $100000.0, $118000.0, and $101000.0 for Q2 2020, Q1 2020, and Q4 2019 respectively.